Proteomics International Laboratories Ltd
ASX:PIQ

Watchlist Manager
Proteomics International Laboratories Ltd Logo
Proteomics International Laboratories Ltd
ASX:PIQ
Watchlist
Price: 0.315 AUD 1.61%
Market Cap: 51.6m AUD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+18%
Revenue
Forecast
+30%
Operating Income
Forecast
+51%
Net Income
Forecast
+95%

Wall Street
Price Targets

PIQ Price Targets Summary
Proteomics International Laboratories Ltd

Wall Street analysts forecast PIQ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PIQ is 0.439 AUD with a low forecast of 0.434 AUD and a high forecast of 0.452 AUD.

PIQ Lowest Forecast
Wall Street Target
0.434 AUD
38% Upside
PIQ Average Forecast
Wall Street Target
0.439 AUD
39% Upside
PIQ Highest Forecast
Wall Street Target
0.452 AUD
43% Upside
Lowest
Price Target
0.434 AUD
38% Upside
Average
Price Target
0.439 AUD
39% Upside
Highest
Price Target
0.452 AUD
43% Upside
Proteomics International Laboratories Ltd Competitors:
Price Targets
688315
Novogene Co Ltd
4% Downside
CDXS
Codexis Inc
170% Upside
DHR
Danaher Corp
19% Upside
688222
HitGen Inc
27% Downside
688315
Novogene Co Ltd
4% Downside
CDXS
Codexis Inc
170% Upside
DHR
Danaher Corp
19% Upside
688222
HitGen Inc
27% Downside
F
FLB
Fluidigm Corp
58% Upside
TKNO
Alpha Teknova Inc
128% Upside
CGEN
Compugen Ltd
399% Upside
MCAP
MedCap AB (publ)
5% Downside

Revenue
Forecast

Revenue Estimate
Proteomics International Laboratories Ltd

For the last 11 years the compound annual growth rate for Proteomics International Laboratories Ltd's revenue is 15%. The projected CAGR for the next 3 years is 44%.

15%
Past Growth
44%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Proteomics International Laboratories Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Proteomics International Laboratories Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
PIQ intrinsic value, competitors valuation, and company profile.
DCF Valuation
PIQ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PIQ stock valuation using valuation multiples.
Wall Street Estimates
PIQ price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PIQ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PIQ's stock price target?
Price Target
0.439 AUD

According to Wall Street analysts, the average 1-year price target for PIQ is 0.439 AUD with a low forecast of 0.434 AUD and a high forecast of 0.452 AUD.

What is Proteomics International Laboratories Ltd's Revenue forecast?
Projected CAGR
44%

For the last 11 years the compound annual growth rate for Proteomics International Laboratories Ltd's revenue is 15%. The projected CAGR for the next 3 years is 44%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 277,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.